Year |
Citation |
Score |
2015 |
Clarke R, Kim W, Groff B, Abujarour R, Robinson M, Huang X, Sahaf N, Raynel S, Rezner B, Robbins D, Guerrettaz L, Shoemaker D, Valamehr B. A Platform for the Scalable Derivation of Genetically-Enhanced T and NK Lymphocytes from Naive Human Induced Pluripotent Stem Cells for Cancer Immunotherapy Blood. 126: 2364-2364. DOI: 10.1182/Blood.V126.23.2364.2364 |
0.445 |
|
2015 |
Guerrettaz L, Sahaf N, Mitchell L, Lynn C, Raynel S, Le T, Foster H, Truong C, Rezner B, Robbins D, Levin WJ, Shoemaker D. Ex Vivo Modulation of Donor Cells Results in Enhanced Survival and Reduced Gvhd Mortality Blood. 126: 1884-1884. DOI: 10.1182/BLOOD.V126.23.1884.1884 |
0.406 |
|
2014 |
Robbins D, Le T, Troung C, Foster H, Rezner B, Mitchell L, Guerrettaz L, Multani PS, Shoemaker D. Ex Vivo Modulation of Mobilized Peripheral Blood: Characterization of HSC and T-Cell Responses to Prostaglandin E2 Blood. 124: 1092-1092. DOI: 10.1182/BLOOD.V124.21.1092.1092 |
0.392 |
|
2011 |
Lukin K, Fields S, Guerrettaz L, Straign D, Rodriguez V, Zandi S, Månsson R, Cambier JC, Sigvardsson M, Hagman J. A dose-dependent role for EBF1 in repressing non-B-cell-specific genes. European Journal of Immunology. 41: 1787-93. PMID 21469119 DOI: 10.1002/Eji.201041137 |
0.42 |
|
2008 |
Guerrettaz LM, Johnson SA, Cambier JC. Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proceedings of the National Academy of Sciences of the United States of America. 105: 11898-902. PMID 18697924 DOI: 10.1073/Pnas.0805498105 |
0.422 |
|
Show low-probability matches. |